319 related articles for article (PubMed ID: 19068408)
1. Brain atrophy assessment in multiple sclerosis: importance and limitations.
Giorgio A; Battaglini M; Smith SM; De Stefano N
Neuroimaging Clin N Am; 2008 Nov; 18(4):675-86, xi. PubMed ID: 19068408
[TBL] [Abstract][Full Text] [Related]
2. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
3. The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.
Bermel RA; Fisher E; Cohen JA
Neuroimaging Clin N Am; 2008 Nov; 18(4):687-701, xi. PubMed ID: 19068409
[TBL] [Abstract][Full Text] [Related]
4. Rate of brain atrophy in benign vs early multiple sclerosis.
Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
[TBL] [Abstract][Full Text] [Related]
5. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
6. Reduction of brain volume in MS. MRI and pathology findings.
Lycklama à Nijeholt GJ
J Neurol Sci; 2005 Jun; 233(1-2):199-202. PubMed ID: 15949505
[TBL] [Abstract][Full Text] [Related]
7. Measurement of whole-brain atrophy in multiple sclerosis.
Pelletier D; Garrison K; Henry R
J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
[TBL] [Abstract][Full Text] [Related]
8. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
[TBL] [Abstract][Full Text] [Related]
9. Brain and spinal cord atrophy in multiple sclerosis.
Simon JH
Neuroimaging Clin N Am; 2000 Nov; 10(4):753-70 ,ix. PubMed ID: 11359723
[TBL] [Abstract][Full Text] [Related]
10. [Multiple sclerosis and magnetic resonance].
Jinochová M; Seidl Z; Obenberger J; Krásenský J; Havrdová E; Viták T; Peterová V; Danes J
Cas Lek Cesk; 2003 Mar; 142(3):144-9. PubMed ID: 12756841
[TBL] [Abstract][Full Text] [Related]
11. Magnetization transfer imaging to monitor clinical trials in multiple sclerosis.
Richert ND; Frank JA
Neurology; 1999; 53(5 Suppl 3):S29-32. PubMed ID: 10496208
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis.
Benedict RH; Bobholz JH
Semin Neurol; 2007 Feb; 27(1):78-85. PubMed ID: 17226744
[TBL] [Abstract][Full Text] [Related]
13. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
14. Update on multiple sclerosis.
Simon JH
Radiol Clin North Am; 2006 Jan; 44(1):79-100, viii. PubMed ID: 16297683
[TBL] [Abstract][Full Text] [Related]
15. Validation of linear cerebral atrophy markers in multiple sclerosis.
Butzkueven H; Kolbe SC; Jolley DJ; Brown JY; Cook MJ; van der Mei IA; Groom PS; Carey J; Eckholdt J; Rubio JP; Taylor BV; Mitchell PJ; Egan GF; Kilpatrick TJ
J Clin Neurosci; 2008 Feb; 15(2):130-7. PubMed ID: 18068987
[TBL] [Abstract][Full Text] [Related]
16. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
17. Tourettism in multiple sclerosis: a case report.
Nociti V; Fasano A; Bentivoglio AR; Frisullo G; Tartaglione T; Tonali PA; Batocchi AP
J Neurol Sci; 2009 Dec; 287(1-2):288-90. PubMed ID: 19695578
[TBL] [Abstract][Full Text] [Related]
18. Visualizing the cause of gray matter atrophy in multiple sclerosis.
Richert ND; Kraft E; Stüve O
Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
[No Abstract] [Full Text] [Related]
19. MRI to monitor treatment efficacy in multiple sclerosis.
Fazekas F; Soelberg-Sorensen P; Comi G; Filippi M
J Neuroimaging; 2007 Apr; 17 Suppl 1():50S-55S. PubMed ID: 17425736
[TBL] [Abstract][Full Text] [Related]
20. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
Ranjeva JP; Audoin B; Pelletier J; Confavreux C
Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
